Phibro Animal Health (PAHC) Misses Q1 EPS by 5c, Revenues Miss; Reaffirms Previous FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Phibro Animal Health Corporation Reports First Quarter Results
November 4, 2019 4:45 PM ESTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its first quarter ended September 30, 2019.
Highlights for the September 2019 quarter (compared to the September 2018 quarter)
Net sales of $190 million, a decrease of $10 million, or 5% Net income of $3 million, a decrease of $14 million, or 85% Diluted EPS of $0.06, a decrease of $0.34, or 85% Adjusted EBITDA of $20 million, a decrease of $10 million, or 35% Adjusted diluted EPS of $0.19, a decrease of $0.20, or... More
